Vector Laboratories' blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Acquisition expands customers’ ability to accelerate their advanced bioconjugate and payload delivery design innovation NEWARK, CalifJuly 17, 2023 Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta... Read more
This blog post covers how glycans and t-cells are connected and their importance in the immune system response.
This blog post covers how glycans contribute to cellular mechanisms of health and disease.
Explore the challenges faced by underrepresented groups in STEM through the eyes of Melina Villasenor, a production supervisor at Vector Laboratories, and learn about the importance of equitable opportunities and inclusive practices.
As a part of Alzheimer’s Disease Month, we will be highlighting research being done to look for a new therapeutic target.
This blog post covers how glycans are being used in new frontiers, such as biomarker discovery for cancer and other research fields.
Lisa V. Sellers, PhD, CEO of Vector Laboratories, discusses strategies for addressing female underrepresentation in STEM fields, emphasizing the role of businesses in sparking early interest in STEM among girls.
Mentorship is crucial in cultivating the next generation of critical thinkers and innovators.
This blog post covers lectin diversity and where lectins come from.
As a part of Huntington’s Disease month, we will be highlighting research being done to look at disease pathogenesis.
